Anne Lesage, Chief Early Development at Pharvaris N.V. (PHVS), sold 76,172 shares at $35.12 ($2.7M) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($2.7M) by Chief Early Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.05 | 6,997 | $245K | 9.1% |
| 2 | $35.05 | 8,300 | $291K | 10.8% |
| 3 | $35.12 | 2,300 | $81K | 3.0% |
| 4 | $35.48 | 27,872 | $989K | 36.7% |
| 5 | $35.49 | 30,703 | $1.1M | 40.4% |
| Total | $35.39 avg | 76,172 |
| $2.7M |
| 100% |
| Filing → |
| PHVS | SELL | 2026-06-29 | $162K | — | Filing → |
| PHVS | SELL | 2026-05-01 | $1.5M | — | Filing → |
| PHVS | SELL | 2026-04-24 | $439K | — | Filing → |